apogemcapital.com Open in urlscan Pro
162.159.134.42  Public Scan

Form analysis
2 forms found in the DOM

GET https://apogemcapital.com/

<form class="header__search-form" role="search" method="get" action="https://apogemcapital.com/">
  <input type="search" name="s" placeholder="Display Search Term" value="">
  <input type="submit" value="Search">
</form>

POST /#wpcf7-f5-o1

<form action="/#wpcf7-f5-o1" method="post" class="wpcf7-form init footer__form-sign" aria-label="Contact form" novalidate="novalidate" data-status="init">
  <div style="display: none;">
    <input type="hidden" name="_wpcf7" value="5">
    <input type="hidden" name="_wpcf7_version" value="5.9.2">
    <input type="hidden" name="_wpcf7_locale" value="en_US">
    <input type="hidden" name="_wpcf7_unit_tag" value="wpcf7-f5-o1">
    <input type="hidden" name="_wpcf7_container_post" value="0">
    <input type="hidden" name="_wpcf7_posted_data_hash" value="">
  </div>
  <p><span class="wpcf7-form-control-wrap" data-name="your-email"><input size="40" class="wpcf7-form-control wpcf7-email wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-email" aria-required="true" aria-invalid="false"
        placeholder="Email Address*" value="" type="email" name="your-email"></span><br>
    <span class="wpcf7-form-control-wrap" data-name="your-name"><input size="40" class="wpcf7-form-control wpcf7-text wpcf7-validates-as-required" aria-required="true" aria-invalid="false" placeholder="Name*" value="" type="text"
        name="your-name"></span><br>
    <input class="wpcf7-form-control wpcf7-submit has-spinner" type="submit" value="Submit"><span class="wpcf7-spinner"></span>
  </p>
  <div class="wpcf7-response-output" aria-hidden="true"></div>
</form>

Text Content

HOW WE USE COOKIES:

We use cookies to provide you with better service and improve our website for
visitors and clients, and we ask you to accept these cookies as described in the
details below. Please note that technically necessary cookies must be set to
ensure that the web pages function properly.
Do not sell or share my personal information
Necessary Only Allow all Show details
OK
Necessary Only Selected Cookies Accept All
Cookies Necessary for the Functioning of Our Site
Preference/Functional Cookies
Statistics and Performance Cookies
Marketing Cookies
Show details
Cookie declaration [#IABV2SETTINGS#] About
 Cookies Necessary for the Functioning of Our Site (3)  Preference/Functional
Cookies (0)  Statistics and Performance Cookies (3)  Marketing Cookies (1)
 Unclassified (0)
Certain cookies are required for our website to function. These necessary
cookies enable core functionality such as security, network management, and
accessibility. While you can disable these cookies in your brower’s settings,
our website may not function as intended.

NameProviderPurposeExpiryTypeCookieConsentCookiebotStores the user's cookie
consent state for the current domain1
yearHTTPwpEmojiSettingsSupportsapogemcapital.comThis cookie is part of a bundle
of cookies which serve the purpose of content delivery and presentation. The
cookies keep the correct state of font, blog/picture sliders, color themes and
other website settings.SessionHTML1.gifCookiebotUsed to count the number of
sessions to the website, necessary for optimizing CMP product delivery.
SessionPixel

Functional cookies allow us to remember certain choices you have made in the
past, including your cookie preferences, location, and investor-type. These
cookies are not used for analytics purposes and are not shared with any third
parties.

We do not use cookies of this type.

We use statistics cookies to collect information about how you use our website,
including pages visited, using information that cannot be used to identify you.
All statistic cookie data are aggregated and anonymized, and their sole purpose
is to improve how our website functions. These cookies may include cookies from
third-party analytics services: Google – How Google Uses Cookies.

NameProviderPurposeExpiryType_gaGoogleRegisters a unique ID that is used to
generate statistical data on how the visitor uses the website.2
yearsHTTP_ga_#GoogleUsed by Google Analytics to collect data on the number of
times a user has visited the website as well as dates for the first and most
recent visit. 2 yearsHTTPtdGoogleRegisters statistical data on users' behaviour
on the website. Used for internal analytics by the website operator.
SessionPixel

These cookies track your online activity to help advertisers deliver more
relevant advertising or to limit how many times you see an ad. These cookies can
share that information with other organizations or advertisers, including
third-parties.

NameProviderPurposeExpiryTypev2/trackerBrightcoveUsed in context with
video-advertisement. The cookie limits the number of times a user is shown the
same advertisement. The cookie is also used to ensure relevance of the
video-advertisement to the specific user. SessionPixel

Unclassified cookies are cookies that we are in the process of classifying,
together with the providers of individual cookies.

We do not use cookies of this type.

 [#IABV2_LABEL_PURPOSES#]  [#IABV2_LABEL_FEATURES#]  [#IABV2_LABEL_PARTNERS#]
[#IABV2_BODY_PURPOSES#]
[#IABV2_BODY_FEATURES#]
[#IABV2_BODY_PARTNERS#]
We use cookies to enable our site to function, improve the performance of our
website, and interact with select third parties as described in the cookie
declaration. While there are cookies that are required for our website to
function, we would also like to set certain cookies that help us improve the
site and provide you with better service as described in the cookie declaration.
These cookies will not be set, however, unless you affirmatively enable them.
Cookie declaration last updated on 13.03.24 by Cookiebot
 * Home
 * About
   * Who We Are
   * History
   * Why Apogem Capital
   * Responsibility
 * Strategies
   * Overview
   * Private Equity
     * Primary Fund Investments
     * Secondary Investments
     * Direct Co-Investments
     * GP Stakes
     * Emerging and Diverse
   * Private Credit
     * Direct Lending
     * Junior Debt
   * Private Real Assets
     * Direct Co-investments
     * Secondary Investments
     * Primary Fund Investments
 * Team
 * News & Insights
 * Careers
   * Apply
   * Benefits
 * Contact
 * Login
   * Apogem Capital
   * RidgeLake Partners



Apogem Capital


YOUR MIDDLE MARKET ALTERNATIVES PARTNER

Learn More

$41B

in AUM

200+

Employees

30+

Years Investing in Alternatives

500+

Clients

Innovative strategies spanning the alternatives landscape, unlocking
opportunities in the middle market for clients and sponsors


PRIVATE EQUITY

Access to the middle market’s growth engine through investments in leading
private companies and funds

 * • Primary Fund Investments
 * • Secondary Investments
 * • Direct Co-Investments
 * • GP Stakes
 * • Emerging and Diverse Investments

Learn More


PRIVATE CREDIT

Financing solutions alongside middle market sponsors, supporting the acquisition
and growth of private companies

 * • Direct Lending
 * • Junior Debt

Learn More


PRIVATE REAL ASSETS

Investments with the potential for lower correlation to public markets,
inflation protection, and attractive total returns

 * • Direct Co-investments
 * • Secondary Investments
 * • Primary Fund Investments

Learn More
Who We Are


EXPERIENCED INVESTOR, STRATEGIC PARTNER

A leading alternatives investor with $41 billion in AUM, Apogem Capital was
formed in 2022 by the combination of three firms with decades of investing
experience. Our clients are invested in select strategies alongside our parent
company, New York Life Insurance Company, one of the largest life insurers in
the world.

Learn More

Why Apogem Capital


SCALE, RESOURCES, RELATIONSHIPS & DATA

With a long-term, multi-cycle track record and deep relationships with hundreds
of sponsors, we seek to uncover attractive opportunities, access highly
sought-after deal flow, and develop innovative solutions for clients and
sponsors.

Learn More


RECENT NEWS & INSIGHTS


APOGEM CAPITAL APPOINTS JOSH NIEDNER AS CHIEF EXECUTIVE OFFICER 
AND CHRIS
STRINGER AS PRESIDENT

January 25, 2024 – Apogem Capital LLC (Apogem), a leading alternatives
investment firm, today announced the appointments of Josh Niedner as Chief
Executive Officer and Chris Stringer as President, effective immediately.

Learn More


RIDGELAKE PARTNERS HOLDS FINAL CLOSE ON $1.1 BILLION FOR ITS INAUGURAL GP STAKES
FUND

January 17, 2024 - Apogem Capital and OA Private Capital today announced the
final closing of their RidgeLake Partners ("RidgeLake") debut middle market
focused GP stakes fund with over $1.1 billion in total commitments.

Learn More


APOGEM CAPITAL APPOINTS JOSHUA NIEDNER AS HEAD OF CREDIT

September 11, 2023 – Apogem Capital LLC (“Apogem”), a leading alternatives
investment firm, today announced the appointment of Joshua Niedner as Head of
Credit.

Learn More


STAY UP TO DATE

To receive email alerts from Apogem, please sign up below.






QUICK LINKS
 * Our Firm
 * Strategies
 * News & Insights
 * Privacy and Cookies
 * Terms & Conditions
 * Sitemap

CONNECT
 * Apogem Capital Login
 * RidgeLake Partners Login
 * Careers
 * Contact

 * 
 * 

 * © 2023 Apogem Capital LLC

 * Website By GCI

AUM is estimated and unaudited as of the December 31, 2023 and includes
non-discretionary and co-advised assets. All other data is the most recent
available unless otherwise noted.

Committed amount represents capital committed to underlying investments by
Apogem Capital and predecessor firms since 1991, including realized investments.

Securities managed by Apogem Capital LLC and distributed through NYLIFE
Distributors LLC, 51 Madison Avenue, New York, NY 10010. NYLIFE Distributors LLC
is an affiliate of New York Life Insurance Company and is a Member of FINRA &
SIPC. For more information on Apogem Capital LLC and its registered persons,
please see SEC Advisor Info, FINRA Brokercheck, and Apogem Capital’s Form CRS.

"New York Life Investments" is both a service mark, and the common trade name,
of certain investment advisors affiliated with New York Life Insurance Company.

The financial strength of New York Life Insurance Company applies only to its
insurance products and not to investment products which are subject to market
risk and fluctuation in value. Individual independent rating agency commentary:
A.M. Best A++ (as of 10/13/21), Fitch Ratings AAA (as of 11/16/21), Moody’s Aaa
(as of 5/6/21), and Standard & Poor’s AA+ (as of 7/21/21).